Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

68 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 22, 2026Jul 22 3:12 PMPendarvis Christiane
Proposed Sale
3,500$32.37$113.3K

View →

Jul 17, 2026Jul 20 8:30 PMOluyemi OkupeChief Financial Officer
Sale
7,163$31.99$229.2K284,321(D)

View →

Jul 6, 2026Jul 7 8:20 PMOluyemi OkupeChief Financial Officer
Sale
7,163$36.49$261.4K284,321(D)

View →

Jul 6, 2026Jul 6 10:17 PMOluyemi Okupe
Proposed Sale
28,652$38.28$1.1M

View →

Jun 18, 2026Jun 23 10:39 PMPatrick Harrison CarrollChief Medical Officer
Sale
23,726$35.00$830.4K181,861(D)

View →

Jun 22, 2026Jun 23 10:39 PMOluyemi OkupeChief Financial Officer
Sale
18,197$34.03$619.2K284,321(D)

View →

Jun 18, 2026Jun 18 7:02 PMCarroll Patrick Harrison
Proposed Sale
23,726$35.00$830.4K

View →

Jun 17, 2026Jun 17 10:50 PMMichael ChiChief Operating Officer
Sale
14,027$31.50$441.9K432,124(D)

View →

Jun 17, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
4,490$31.50$141.4K6,790(D)

View →

Jun 16, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
7,573$30.25$229.1K11,280(D)

View →

Jun 17, 2026Jun 17 10:50 PMMohamed ElshenawyCTO
Sale
30,040$31.50$946.3K101,023(D)

View →

Jun 17, 2026Jun 17 3:17 PMBecklund Irene
Proposed Sale
4,490$31.50$141.4K

View →

Jun 17, 2026Jun 17 3:10 PMElshenawy Mohamed
Proposed Sale
30,040$31.50$946.3K

View →

Jun 17, 2026Jun 17 1:47 PMChi Michael
Proposed Sale
14,027$31.50$441.9K

View →

Jun 16, 2026Jun 16 3:21 PMBecklund Irene
Proposed Sale
7,573$30.25$229.1K

View →

May 26, 2026May 26 8:48 PMDavid B WellsDirector
Purchase
48,400$24.24$1.2M224,417(D)

View →

May 18, 2026May 19 11:39 PMOluyemi OkupeChief Financial Officer
Sale
7,950$23.64$187.9K262,954(D)

View →

Apr 20, 2026Apr 22 9:24 PMSoleil BoughtonChief Legal Officer
Sale
9,463$30.00$283.9K299,368(D)

View →

Apr 20, 2026Apr 22 9:24 PMOluyemi OkupeChief Financial Officer
Sale
19,645$29.96$588.6K262,954(D)

View →

Apr 17, 2026Apr 20 8:38 PMOluyemi OkupeChief Financial Officer
Sale
18,005$27.83$501.2K270,046(D)

View →

Page 1 of 10

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,2110(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,52242,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919493,792(D)

View →

Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,98716,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,42174,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,07662,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 3 of 3